Signatur Biosciences
ActiveSimple tests for complex diseases.
What it does
We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.
Its site says now · captured 2026-08-23
Signatur Biosciences :: Expanding PCR testing to a whole new range of conditions
Expanding PCR testing to a whole new range of conditions. Making precision diagnostics accessible around the planet. Our technology leverages widely accessible PCR instrumentation to perform simple diagnosis that would otherwise require complex, expensive machines.
Next to it in Healthcare and bio · precision diagnostics for cancer prognosis
- Yemaachi BiotechnologyY Combinator S21
Diversifying precision cancer diagnostics and treatments
- NearWaveY Combinator W22
Helping physicians select the right therapy for breast cancer patients
- AOA DxY Combinator S21
Blood Test for Early Detection of Ovarian Cancer
- NumenY Combinator S23
Engineering a future without cancer deaths.
- Asima Health Inc.Plug and Play PnP 2024
World's fastest, simplest and cheapest pan-cancer screening platform.
- CrosscopeTechstars TS 2020
Crosscope | Next Generation Pathology
- Data Driven BioscienceY Combinator S18
Cancer Diagnosis 10X faster, 10X cheaper
- StarlingY Combinator W22
AI enabling digital urine diagnostics in the home